Cargando…

P166 Measures of overnight sleep stability in patients with hypersomnolence

INTRODUCTION: Hypersomnolence causes significant impairment of daytime functioning. The multiple sleep latency test (MSLT) measures objective hypersomnolence (OH). Patients with hypersomnolence with a normal MSLT are said to have subjective hypersomnolence (SH). The mechanisms of hypersomnolence in...

Descripción completa

Detalles Bibliográficos
Autores principales: Woods, S, Frenkel, S, Lopez, C, Murnane, C, Southcott, A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10108981/
http://dx.doi.org/10.1093/sleepadvances/zpab014.205
_version_ 1785026958118092800
author Woods, S
Frenkel, S
Lopez, C
Murnane, C
Southcott, A
author_facet Woods, S
Frenkel, S
Lopez, C
Murnane, C
Southcott, A
author_sort Woods, S
collection PubMed
description INTRODUCTION: Hypersomnolence causes significant impairment of daytime functioning. The multiple sleep latency test (MSLT) measures objective hypersomnolence (OH). Patients with hypersomnolence with a normal MSLT are said to have subjective hypersomnolence (SH). The mechanisms of hypersomnolence in such patients is uncertain. This study describes differences in measures of sleep stability derived from the overnight polysomnography (PSG) in patients with OH and SH. METHODS: A retrospective analysis of 100 patients undergoing PSG/MSLT for investigation of hypersomnolence was performed. Patients were classified as OH (MSLT≤8 min) or SH (MSLT>8min). Sleep stage distribution and PSG-derived markers of sleep stability including cardiopulmonary coupling (CPC), cyclic alternating pattern (CAP) and sleep stage shifts were compared between the two groups. RESULTS: When compared to OH patients (N=50), SH patients (N=50) had significantly more sleep stage shifts, more shifts to stage N1 and longer PSG sleep latency. Small but significantly lower sleep efficiency, higher stage N1 and N3 proportions were also observed in SH patients. OH patients had a small but significantly higher CAP rate and CAP index compared to SH patients. There were no significant differences in CPC metrics between the two groups. CONCLUSION: Several PSG-derived markers of sleep stability indicated that patients with SH experienced more unstable sleep than OH patients. This may provide insight into the underlying pathophysiological mechanisms which differentiate these patient groups and may serve as a future therapeutic target.
format Online
Article
Text
id pubmed-10108981
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-101089812023-05-15 P166 Measures of overnight sleep stability in patients with hypersomnolence Woods, S Frenkel, S Lopez, C Murnane, C Southcott, A Sleep Adv Poster Presentations INTRODUCTION: Hypersomnolence causes significant impairment of daytime functioning. The multiple sleep latency test (MSLT) measures objective hypersomnolence (OH). Patients with hypersomnolence with a normal MSLT are said to have subjective hypersomnolence (SH). The mechanisms of hypersomnolence in such patients is uncertain. This study describes differences in measures of sleep stability derived from the overnight polysomnography (PSG) in patients with OH and SH. METHODS: A retrospective analysis of 100 patients undergoing PSG/MSLT for investigation of hypersomnolence was performed. Patients were classified as OH (MSLT≤8 min) or SH (MSLT>8min). Sleep stage distribution and PSG-derived markers of sleep stability including cardiopulmonary coupling (CPC), cyclic alternating pattern (CAP) and sleep stage shifts were compared between the two groups. RESULTS: When compared to OH patients (N=50), SH patients (N=50) had significantly more sleep stage shifts, more shifts to stage N1 and longer PSG sleep latency. Small but significantly lower sleep efficiency, higher stage N1 and N3 proportions were also observed in SH patients. OH patients had a small but significantly higher CAP rate and CAP index compared to SH patients. There were no significant differences in CPC metrics between the two groups. CONCLUSION: Several PSG-derived markers of sleep stability indicated that patients with SH experienced more unstable sleep than OH patients. This may provide insight into the underlying pathophysiological mechanisms which differentiate these patient groups and may serve as a future therapeutic target. Oxford University Press 2021-10-07 /pmc/articles/PMC10108981/ http://dx.doi.org/10.1093/sleepadvances/zpab014.205 Text en © The Author(s) 2021. Published by Oxford University Press on behalf of Sleep Research Society. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence (https://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited. For commercial re-use, please contact journals.permissions@oup.com
spellingShingle Poster Presentations
Woods, S
Frenkel, S
Lopez, C
Murnane, C
Southcott, A
P166 Measures of overnight sleep stability in patients with hypersomnolence
title P166 Measures of overnight sleep stability in patients with hypersomnolence
title_full P166 Measures of overnight sleep stability in patients with hypersomnolence
title_fullStr P166 Measures of overnight sleep stability in patients with hypersomnolence
title_full_unstemmed P166 Measures of overnight sleep stability in patients with hypersomnolence
title_short P166 Measures of overnight sleep stability in patients with hypersomnolence
title_sort p166 measures of overnight sleep stability in patients with hypersomnolence
topic Poster Presentations
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10108981/
http://dx.doi.org/10.1093/sleepadvances/zpab014.205
work_keys_str_mv AT woodss p166measuresofovernightsleepstabilityinpatientswithhypersomnolence
AT frenkels p166measuresofovernightsleepstabilityinpatientswithhypersomnolence
AT lopezc p166measuresofovernightsleepstabilityinpatientswithhypersomnolence
AT murnanec p166measuresofovernightsleepstabilityinpatientswithhypersomnolence
AT southcotta p166measuresofovernightsleepstabilityinpatientswithhypersomnolence